Strategic Investment Advisors / MI

Position in DFTX — Definium Therapeutics, Inc.

CIK 1760540 FARMINGTON HILLS, MI

Position in DFTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$110,308

New position

Shares Held

2,345

first reported quarter

Ownership

0.002%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#283

of 358 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Strategic Investment Advisors / MI holds $2,978,396 across 4 Biotechnology names. DFTX ranks #4 (3.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	43,048	$2,342,241
2	VRTX	Vertex Pharmaceuticals Inc / Ma	746	$370,560
3	GMAB	Genmab A/S	5,653	$155,287
4	DFTX	Definium Therapeutics, Inc. This page	2,345	$110,308

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$110,308	2,345	—	Shares	Sole	2026-08-14
No filing history on record for this holder in this stock.